Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson(National Institutes of Health), Ryan M. Young(National Institutes of Health), Roland Schmitz(National Institutes of Health), Yandan Yang(National Institutes of Health), Stefania Pittaluga(National Institutes of Health), George W. Wright(National Institutes of Health), Chih-Jian Lih(Frederick National Laboratory for Cancer Research), P. Mickey Williams(Frederick National Laboratory for Cancer Research), Arthur L. Shaffer(National Institutes of Health), John F. Gerecitano(Memorial Sloan Kettering Cancer Center), Sven de Vos(University of California, Los Angeles), André Goy(Rutgers, The State University of New Jersey), Vaishalee P. Kenkre(University of Wisconsin–Madison), Paul M. Barr(University of Rochester), Kristie A. Blum(The Ohio State University), Andrei R. Shustov(University of Washington), Ranjana H. Advani(Stanford Medicine), Nathan Fowler(The University of Texas MD Anderson Cancer Center), Julie M. Vose(University of Nebraska at Omaha), Rebecca Elstrom(Acentech (United States)), Thomas M. Habermann(Mayo Clinic), Jacqueline C. Barrientos(Hofstra University), Jesse McGreivy(Pharmacyclics (United States)), Maria Fardis(Pharmacyclics (United States)), Betty Chang(Pharmacyclics (United States)), Fong Clow(Pharmacyclics (United States)), Brian Munneke(Pharmacyclics (United States)), Davina Moussa(Pharmacyclics (United States)), Darrin M. Beaupre(Pharmacyclics (United States)), Louis M. Staudt(National Institutes of Health)
Cited by 1,109Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis